Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B
Open Access
- 18 October 2023
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 80 (1) , 41-52
Abstract
No abstract availableKeywords
Funding Information
- National Mega Project on Major Infectious Disease Prevention
- National Natural Science Foundation of China (82072280)
- National Natural Science Foundation of China (82272315)
- Natural Science Foundation of Beijing Municipality
- National Key Research and Development Program of China (2022YFA1303600)
- National Major Science and Technology Projects of China (2017ZX10202203)
This publication has 25 references indexed in Scilit:
- HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levelsJournal of Hepatology, 2014
- STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppressionProceedings of the National Academy of Sciences, 2014
- New loci associated with chronic hepatitis B virus infection in Han ChineseNature Genetics, 2013
- Hepatitis B virus subgenotype C2 is the most prevalent subgenotype in northeast ChinaClinical Microbiology and Infection, 2010
- Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-AlfaGastroenterology, 2009
- HIV-1 transactivator protein induction of suppressor of cytokine signaling-2 contributes to dysregulation of IFNγ signalingBlood, 2009
- Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage–response thresholdsProceedings of the National Academy of Sciences, 2009
- An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infectionProceedings of the National Academy of Sciences, 2006
- The Human Genome Browser at UCSCGenome Research, 2002
- Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2Science, 1996